Sign In
Get Clay Free →

Suggestions

    Ann-Marie Redmond

    Impassioned Market Access Leader supporting value driven access to innovative therapies | Pharma & Biotech | Early Commercialization | Rare Disease

    Ann-Marie Redmond is a committed healthcare leader currently serving as the Head of Market Access & Pricing for North America at Egetis Therapeutics US.1 With a background from Fordham University, she is dedicated to developing innovative yet practical solutions in the healthcare industry.1

    Professional Background

    Ann-Marie's LinkedIn profile highlights her role in the pharmaceutical sector, specifically in market access and pricing strategies for the North American market. Her position at Egetis Therapeutics US suggests she plays a crucial role in determining how the company's products are priced and accessed in this region.1

    Expertise and Focus

    As a healthcare leader, Ann-Marie Redmond's work likely involves:

    • Developing pricing strategies for pharmaceutical products
    • Negotiating with insurance companies and healthcare providers
    • Ensuring market access for Egetis Therapeutics' treatments
    • Analyzing market trends and competitor pricing
    • Collaborating with cross-functional teams to align market access strategies with overall business objectives

    Her commitment to innovative yet practical solutions indicates a balanced approach to addressing complex healthcare market challenges.1

    Education

    Ann-Marie Redmond's educational background includes studies at Fordham University, which has likely contributed to her expertise in the healthcare and pharmaceutical industries.1

    It's worth noting that while there are several professionals named Ann-Marie Redmond on LinkedIn, the specific profile mentioned in the query (with the username ann-marie-redmond-0a464118) corresponds to the Head of Market Access & Pricing for North America at Egetis Therapeutics US.12

    Related Questions

    What are Ann-Marie Redmond's key achievements at Egetis Therapeutics US?
    How did Ann-Marie Redmond transition from Fordham University to her current role?
    What innovative solutions has Ann-Marie Redmond developed in her career?
    What is Ann-Marie Redmond's educational background?
    How does Ann-Marie Redmond's experience at Egetis Therapeutics US compare to her previous roles?